Haleon Invests $87.2 Million in Shanghai Oral Health Plant

Haleon is committing $87.2 million to establish a new oral health facility in Shanghai, aiming to expand its presence in key markets such as China and India. Bloomberg posted on X, highlighting the company's strategic focus on these regions to bolster growth. The investment underscores Haleon's dedication to enhancing its consumer health offerings and tapping into the growing demand for oral health products in Asia. This move is part of a broader strategy to capitalize on emerging markets, which are increasingly pivotal for global consumer health companies seeking to diversify and strengthen their portfolios.